UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Case for continuing community NIV and CPAP during the COVID-19 epidemic

Thorax, 2020-05, Vol.75 (5), p.368

2020

Link zum Volltext

Verfügbarkeit prüfen

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors

Pharmacology research & perspectives, 2022-04, Vol.10 (2), p.e00936-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

The signaling and selectivity of α‐adrenoceptor agonists for the human α2A, α2B and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors

Pharmacology research & perspectives, 2022-10, Vol.10 (5), p.e01003-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

The selectivity of β‐adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors

British journal of pharmacology, 2005-02, Vol.144 (3), p.317-322

Baker, Jillian G

2005

Link zum Volltext

Verfügbarkeit prüfen

A full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptors

PloS one, 2010-11, Vol.5 (11), p.e15487

2010

Link zum Volltext

Verfügbarkeit prüfen

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors

Pharmacology research & perspectives, 2020-08, Vol.8 (4), p.e00602-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

The selectivity of α‐adrenoceptor agonists for the human α1A, α1B, and α1D‐adrenoceptors

Pharmacology research & perspectives, 2021-08, Vol.9 (4), p.e00799-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

β-Blockers, heart disease and COPD: current controversies and uncertainties

Thorax, 2017-03, Vol.72 (3), p.271

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of polymorphic variants on the molecular pharmacology of the two-agonist conformations of the human β1-adrenoceptor

PloS one, 2013-11, Vol.8 (11), p.e77582-e77582

2013

Link zum Volltext

Verfügbarkeit prüfen

New Fluorescent Adenosine A1-Receptor Agonists That Allow Quantification of Ligand−Receptor Interactions in Microdomains of Single Living Cells

Journal of medicinal chemistry, 2007-02, Vol.50 (4), p.782-793

2007

Link zum Volltext

Verfügbarkeit prüfen

The structural basis for agonist and partial agonist action on a β1-adrenergic receptor

Nature (London), 2011-01, Vol.469 (7329), p.241-244

2011

Link zum Volltext

Verfügbarkeit prüfen

The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor

Nature (London), 2011-01, Vol.469 (7329), p.241

2011

Link zum Volltext

Verfügbarkeit prüfen

Structure of a β1-adrenergic G-protein-coupled receptor

Nature (London), 2008-07, Vol.454 (7203), p.486-491

2008

Link zum Volltext

Verfügbarkeit prüfen

Rational design, synthesis, and pharmacological evaluation of a cohort of novel beta-adrenergic receptors ligands enables an assessment of structure-activity relationships

European journal of medicinal chemistry, 2023-01, Vol.246, p.114961-114961, Article 114961

2023

Link zum Volltext

Verfügbarkeit prüfen

Structure-Based Discovery of Novel Ligands for the Orexin 2 Receptor

Journal of medicinal chemistry, 2020-10, Vol.63 (19), p.11045-11053

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparative Docking to Distinct G Protein-Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy

Molecular pharmacology, 2019-12, Vol.96 (6), p.851-861

2019

Link zum Volltext

Verfügbarkeit prüfen

The Isoleucine at Position 118 in Transmembrane 2 Is Responsible for the Selectivity of Xamoterol, Nebivolol, and ICI89406 for the Human β 1-Adrenoceptor

Molecular pharmacology, 2023-02, Vol.103 (2), p.89-99

2023

Link zum Volltext

Verfügbarkeit prüfen

Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling

Trends in pharmacological sciences (Regular ed.), 2011-04, Vol.32 (4), p.227-234

2011

Link zum Volltext

Verfügbarkeit prüfen

Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients

European journal of cancer (1990), 2021-04, Vol.147, p.106-116

2021

Link zum Volltext

Verfügbarkeit prüfen

Fragment evolution for GPCRs: the role of secondary binding sites in optimization

Chemical communications (Cambridge, England), 2021-10, Vol.57 (81), p.1516-1519

2021

Link zum Volltext

Verfügbarkeit prüfen

Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates

Trends in pharmacological sciences (Regular ed.), 2007-08, Vol.28 (8), p.374-381

2007

Link zum Volltext

Verfügbarkeit prüfen

Negative cooperativity across β1‐adrenoceptor homodimers provides insights into the nature of the secondary low‐affinity CGP 12177 β1‐adrenoceptor binding conformation

The FASEB journal, 2015-07, Vol.29 (7), p.2859-2871

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological and SAR analysis of the LINS01 compounds at the human histamine H 1 , H 2 , and H 3 receptors

Chemical biology & drug design, 2019-01, Vol.93 (1), p.89

2019

Link zum Volltext

Verfügbarkeit prüfen

Influence of Agonist Efficacy and Receptor Phosphorylation on Antagonist Affinity Measurements: Differences between Second Messenger and Reporter Gene Responses

Molecular pharmacology, 2003-09, Vol.64 (3), p.679-688

2003

Link zum Volltext

Verfügbarkeit prüfen

Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A, receptor ligands

British journal of pharmacology, 2010, Vol.159 (4), p.772-786

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Englisch
(149)

Erscheinungsjahr

n.n

Thema

Science & Technology
(58)
Humans
(57)
Life Sciences & Biomedicine
(49)
Animals
(40)
Cho Cells
(30)
Cricetinae
(27)
Cricetulus
(21)
Ligands
(21)
Pharmacology & Pharmacy
(17)
Biological And Medical Sciences
(16)
Male
(16)
Cyclic Amp - Metabolism
(14)
Adrenergic Beta-Antagonists - Pharmacology
(12)
Genomics
(12)
Receptors, Adrenergic, Beta-1 - Metabolism
(12)
Adrenergic Beta-Agonists - Pharmacology
(11)
Receptors, Adrenergic, Beta-1 - Chemistry
(11)
Protein Conformation
(10)
Adrenergic Beta-Antagonists - Metabolism
(9)
Bacteria
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Case for continuing community NIV and CPAP during the COVID-19 epidemic

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors

The signaling and selectivity of α‐adrenoceptor agonists for the human α2A, α2B and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors

The selectivity of β‐adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors

A full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptors

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors

The selectivity of α‐adrenoceptor agonists for the human α1A, α1B, and α1D‐adrenoceptors

β-Blockers, heart disease and COPD: current controversies and uncertainties

Impact of polymorphic variants on the molecular pharmacology of the two-agonist conformations of the human β1-adrenoceptor

New Fluorescent Adenosine A1-Receptor Agonists That Allow Quantification of Ligand−Receptor Interactions in Microdomains of Single Living Cells

The structural basis for agonist and partial agonist action on a β1-adrenergic receptor

The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor

Structure of a β1-adrenergic G-protein-coupled receptor

Rational design, synthesis, and pharmacological evaluation of a cohort of novel beta-adrenergic receptors ligands enables an assessment of structure-activity relationships

Structure-Based Discovery of Novel Ligands for the Orexin 2 Receptor

Comparative Docking to Distinct G Protein-Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy

The Isoleucine at Position 118 in Transmembrane 2 Is Responsible for the Selectivity of Xamoterol, Nebivolol, and ICI89406 for the Human β 1-Adrenoceptor

Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling

Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients

Fragment evolution for GPCRs: the role of secondary binding sites in optimization

Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates

Negative cooperativity across β1‐adrenoceptor homodimers provides insights into the nature of the secondary low‐affinity CGP 12177 β1‐adrenoceptor binding conformation

Pharmacological and SAR analysis of the LINS01 compounds at the human histamine H 1 , H 2 , and H 3 receptors

Influence of Agonist Efficacy and Receptor Phosphorylation on Antagonist Affinity Measurements: Differences between Second Messenger and Reporter Gene Responses

Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A, receptor ligands

Suchergebnisse filtern